Elysium Health

A new era for sunscreen?

Plus: NAD+ and retinal health, GLP-1s, labor timing, and brain plasticity.

Elysium Health announces the FDA's approval of a new sunscreen active ingredient, bemotrizinol, for the first time in decades. The company offers expert commentary from Dr. Richard Granstein on the benefits of bemotrizinol, which provides broad-spectrum protection against UVA and UVB rays. Elysium Health also highlights other research topics in its July edition of The Abstract.

Newsletters email from Elysium Health, sent Jul 19, 2026.